Celgene (CELG) Updates on Multiple REVLIMID Trials in Treating NHL StreetInsider.com (subscription) The presented data included two Phase II trials on the combination of lenalidomide with R-CHOP, a Phase I/II trial evaluating the combination of lenalidomide and ofatumumab, and a Phase II trial analyzing the combination of lenalidomide and rituximab. Results of Pivotal Study (MCL-001) Evaluating REVLIMID in Mantle-Cell ... |
